Epitomee Medical Valuation

EPIT Stock   938.20  30.20  3.33%   
At this time, the firm appears to be overvalued. Epitomee Medical shows a prevailing Real Value of USD743.21 per share. The current price of the firm is USD938.2. Our model computes the value of Epitomee Medical from reviewing the firm fundamentals such as Shares Owned By Insiders of 56.83 %, number of employees of 6, and Market Capitalization of 318.32 M as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
938.20
Please note that Epitomee Medical's price fluctuation is very steady at this time. Calculation of the real value of Epitomee Medical is based on 3 months time horizon. Increasing Epitomee Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Epitomee Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Epitomee Stock. However, Epitomee Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  938.2 Real  743.21 Hype  938.2 Naive  1023.32
The real value of Epitomee Stock, also known as its intrinsic value, is the underlying worth of Epitomee Medical Company, which is reflected in its stock price. It is based on Epitomee Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Epitomee Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
705.78
Downside
743.21
Real Value
1,032
Upside
Estimating the potential upside or downside of Epitomee Medical helps investors to forecast how Epitomee stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Epitomee Medical more accurately as focusing exclusively on Epitomee Medical's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
899.66928.13956.61
Details
Hype
Prediction
LowEstimatedHigh
900.77938.20975.63
Details
Naive
Forecast
LowNext ValueHigh
985.891,0231,061
Details

Epitomee Medical Total Value Analysis

Epitomee Medical is currently forecasted to have takeover price of 339.18 M with market capitalization of 318.32 M, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Epitomee Medical fundamentals before making investing decisions based on enterprise value of the company

Epitomee Medical Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Epitomee suggests not a very effective usage of assets in November.

Epitomee Medical Ownership Allocation

Epitomee Medical holds a total of 29.58 Million outstanding shares. Epitomee Medical retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Epitomee Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Epitomee Medical and how it compares across the competition.

About Epitomee Medical Valuation

The stock valuation mechanism determines Epitomee Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Epitomee Medical. We calculate exposure to Epitomee Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Epitomee Medical's related companies.

8 Steps to conduct Epitomee Medical's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Epitomee Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Epitomee Medical's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Epitomee Medical's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Epitomee Medical's revenue streams: Identify Epitomee Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Epitomee Medical's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Epitomee Medical's growth potential: Evaluate Epitomee Medical's management, business model, and growth potential.
  • Determine Epitomee Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Epitomee Medical's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for Epitomee Stock analysis

When running Epitomee Medical's price analysis, check to measure Epitomee Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epitomee Medical is operating at the current time. Most of Epitomee Medical's value examination focuses on studying past and present price action to predict the probability of Epitomee Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Epitomee Medical's price. Additionally, you may evaluate how the addition of Epitomee Medical to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements